Implementation of a reference standard and proficiency testing programme by the World Wide Antimalarial Resistance Network (WWARN)

<p>Abstract</p> <p>Background</p> <p>The Worldwide Antimalarial Resistance Network (WWARN) is a global collaboration to support the objective that anyone affected by malaria receives effective and safe drug treatment. The Pharmacology module aims to inform optimal anti-...

Full description

Bibliographic Details
Main Authors: Barnes Karen I, Watkins William M, Lourens Chris, Sibley Carol H, Guerin Philippe J, White Nicholas J, Lindegardh Niklas
Format: Article
Language:English
Published: BMC 2010-12-01
Series:Malaria Journal
Online Access:http://www.malariajournal.com/content/9/1/375
_version_ 1818568352124108800
author Barnes Karen I
Watkins William M
Lourens Chris
Sibley Carol H
Guerin Philippe J
White Nicholas J
Lindegardh Niklas
author_facet Barnes Karen I
Watkins William M
Lourens Chris
Sibley Carol H
Guerin Philippe J
White Nicholas J
Lindegardh Niklas
author_sort Barnes Karen I
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>The Worldwide Antimalarial Resistance Network (WWARN) is a global collaboration to support the objective that anyone affected by malaria receives effective and safe drug treatment. The Pharmacology module aims to inform optimal anti-malarial drug selection. There is an urgent need to define the drug exposure - effect relationship for most anti-malarial drugs. Few anti-malarials have had their therapeutic blood concentration levels defined. One of the main challenges in assessing safety and efficacy data in relation to drug concentrations is the comparability of data generated from different laboratories. To explain differences in anti-malarial pharmacokinetics in studies with different measurement laboratories it is necessary to confirm the accuracy of the assay methods. This requires the establishment of an external quality assurance process to assure results that can be compared. This paper describes this process.</p> <p>Methods</p> <p>The pharmacology module of WWARN has established a quality assurance/quality control (QA/QC) programme consisting of two separate components:</p> <p indent="1">1. A proficiency testing programme where blank human plasma spiked with certified reference material (CRM) in different concentrations is sent out to participating bioanalytical laboratories.</p> <p indent="1">2. A certified reference standard programme where accurately weighed amounts of certified anti-malarial reference standards, metabolites, and internal standards are sent to participating bioanalytical and in vitro laboratories.</p> <p>Conclusion</p> <p>The proficiency testing programme is designed as a cooperative effort to help participating laboratories assess their ability to carry out drug analysis, resolve any potential problem areas and to improve their results - and, in so doing, to improve the quality of anti-malarial pharmacokinetic data published and shared with WWARN.</p> <p>By utilizing the same source of standards for all laboratories, it is possible to minimize bias arising from poor quality reference standards. By providing anti-malarial drug standards from a central point, it is possible to lower the cost of these standards.</p>
first_indexed 2024-12-14T06:34:42Z
format Article
id doaj.art-2a1bd37ca3124fc383826920b4f06fa1
institution Directory Open Access Journal
issn 1475-2875
language English
last_indexed 2024-12-14T06:34:42Z
publishDate 2010-12-01
publisher BMC
record_format Article
series Malaria Journal
spelling doaj.art-2a1bd37ca3124fc383826920b4f06fa12022-12-21T23:13:24ZengBMCMalaria Journal1475-28752010-12-019137510.1186/1475-2875-9-375Implementation of a reference standard and proficiency testing programme by the World Wide Antimalarial Resistance Network (WWARN)Barnes Karen IWatkins William MLourens ChrisSibley Carol HGuerin Philippe JWhite Nicholas JLindegardh Niklas<p>Abstract</p> <p>Background</p> <p>The Worldwide Antimalarial Resistance Network (WWARN) is a global collaboration to support the objective that anyone affected by malaria receives effective and safe drug treatment. The Pharmacology module aims to inform optimal anti-malarial drug selection. There is an urgent need to define the drug exposure - effect relationship for most anti-malarial drugs. Few anti-malarials have had their therapeutic blood concentration levels defined. One of the main challenges in assessing safety and efficacy data in relation to drug concentrations is the comparability of data generated from different laboratories. To explain differences in anti-malarial pharmacokinetics in studies with different measurement laboratories it is necessary to confirm the accuracy of the assay methods. This requires the establishment of an external quality assurance process to assure results that can be compared. This paper describes this process.</p> <p>Methods</p> <p>The pharmacology module of WWARN has established a quality assurance/quality control (QA/QC) programme consisting of two separate components:</p> <p indent="1">1. A proficiency testing programme where blank human plasma spiked with certified reference material (CRM) in different concentrations is sent out to participating bioanalytical laboratories.</p> <p indent="1">2. A certified reference standard programme where accurately weighed amounts of certified anti-malarial reference standards, metabolites, and internal standards are sent to participating bioanalytical and in vitro laboratories.</p> <p>Conclusion</p> <p>The proficiency testing programme is designed as a cooperative effort to help participating laboratories assess their ability to carry out drug analysis, resolve any potential problem areas and to improve their results - and, in so doing, to improve the quality of anti-malarial pharmacokinetic data published and shared with WWARN.</p> <p>By utilizing the same source of standards for all laboratories, it is possible to minimize bias arising from poor quality reference standards. By providing anti-malarial drug standards from a central point, it is possible to lower the cost of these standards.</p>http://www.malariajournal.com/content/9/1/375
spellingShingle Barnes Karen I
Watkins William M
Lourens Chris
Sibley Carol H
Guerin Philippe J
White Nicholas J
Lindegardh Niklas
Implementation of a reference standard and proficiency testing programme by the World Wide Antimalarial Resistance Network (WWARN)
Malaria Journal
title Implementation of a reference standard and proficiency testing programme by the World Wide Antimalarial Resistance Network (WWARN)
title_full Implementation of a reference standard and proficiency testing programme by the World Wide Antimalarial Resistance Network (WWARN)
title_fullStr Implementation of a reference standard and proficiency testing programme by the World Wide Antimalarial Resistance Network (WWARN)
title_full_unstemmed Implementation of a reference standard and proficiency testing programme by the World Wide Antimalarial Resistance Network (WWARN)
title_short Implementation of a reference standard and proficiency testing programme by the World Wide Antimalarial Resistance Network (WWARN)
title_sort implementation of a reference standard and proficiency testing programme by the world wide antimalarial resistance network wwarn
url http://www.malariajournal.com/content/9/1/375
work_keys_str_mv AT barneskareni implementationofareferencestandardandproficiencytestingprogrammebytheworldwideantimalarialresistancenetworkwwarn
AT watkinswilliamm implementationofareferencestandardandproficiencytestingprogrammebytheworldwideantimalarialresistancenetworkwwarn
AT lourenschris implementationofareferencestandardandproficiencytestingprogrammebytheworldwideantimalarialresistancenetworkwwarn
AT sibleycarolh implementationofareferencestandardandproficiencytestingprogrammebytheworldwideantimalarialresistancenetworkwwarn
AT guerinphilippej implementationofareferencestandardandproficiencytestingprogrammebytheworldwideantimalarialresistancenetworkwwarn
AT whitenicholasj implementationofareferencestandardandproficiencytestingprogrammebytheworldwideantimalarialresistancenetworkwwarn
AT lindegardhniklas implementationofareferencestandardandproficiencytestingprogrammebytheworldwideantimalarialresistancenetworkwwarn